Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase"
- PMID: 36710605
- PMCID: PMC10121290
- DOI: 10.3350/cmh.2023.0018
Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase"
Keywords: Age; Alanine aminotransferase; Chronic hepatitis B; Hepatitis B virus; Immune tolerance.
Conflict of interest statement
The authors have no conflicts to disclose.
Comment in
-
Correspondence on Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase".Clin Mol Hepatol. 2023 Apr;29(2):513-515. doi: 10.3350/cmh.2023.0044. Epub 2023 Feb 15. Clin Mol Hepatol. 2023. PMID: 36788758 Free PMC article. No abstract available.
Comment on
-
Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase.Clin Mol Hepatol. 2023 Apr;29(2):482-495. doi: 10.3350/cmh.2022.0322. Epub 2023 Jan 5. Clin Mol Hepatol. 2023. PMID: 36603573 Free PMC article.
References
-
- Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, et al. Hong Kong Liver Fibrosis Study Group Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology. 2007;46:395–401. - PubMed
-
- Andreani T, Serfaty L, Mohand D, Dernaika S, Wendum D, Chazouillères O, et al. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome. Clin Gastroenterol Hepatol. 2007;5:636–641. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
